Integrated Absence Management: Preventing Opioid Deaths

Tasha Patterson@Work


Preventing Opioid Deaths: An Opportunity to Integrate Health and Disability Management

Preventing Opioid DeathsBy Glenn Pransky, MD

Scientific Advisor
Lincoln Financial Group

Prescription opioid abuse has increased, with a surge in deaths from high-potency synthetic opioids, resulting in over 150 opioid-related deaths each day in the United States — nearly a four-fold increase over the last 15 years.1 Of 10.6 million Americans with opioid use disorder in 2016, over 62% were employed.2 The costs to employers in terms of absence, poor work quality and productivity, occupational injuries, healthcare costs, and other losses are considerable.3 Unfortunately, employed persons are only half as likely to receive treatment for substance abuse as unemployed persons.2

Guidelines are available on how to achieve a drug-free workplace, including workplace policies, drug screening, and employee education.4,5 Yet most employers feel unprepared to identify opioid use disorders in the workplace, and support treatment and recovery.6

Full content is available to DMEC members only. Log in to view the complete resource.

If you are not a DMEC member, we encourage you to join. DMEC members have access to white papers, case studies, @Work magazine articles, free webinars, legislative updates, and much more. These resources will assist you in building an effective and compliant integrated absence management program, saving you time, resources, and money. Learn more.

If you are being asked to log in more than once, please refresh your browser.